Marder SR - Search Results

1

A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.

Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA. Jarskog LF, et al. Among authors: marder sr. Schizophr Res. 2015 May;164(1-3):136-42. doi: 10.1016/j.schres.2015.01.041. Epub 2015 Feb 24. Schizophr Res. 2015. PMID: 25728831 Clinical Trial.

2

Drug treatment of schizophrenia. Overview of recent research.

Marder SR, Wirshing WC, Van Putten T. Marder SR, et al. Schizophr Res. 1991 Mar-Apr;4(2):81-90. doi: 10.1016/0920-9964(91)90027-o. Schizophr Res. 1991. PMID: 1674883 Review.

3

Antipsychotic drugs and relapse prevention.

Marder SR. Marder SR. Schizophr Res. 1999 Mar 1;35 Suppl:S87-92. doi: 10.1016/s0920-9964(98)00167-4. Schizophr Res. 1999. PMID: 10190229 Review.

4

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

Kern RS, Green MF, Marshall BD Jr, Wirshing WC, Wirshing D, McGurk SR, Marder SR, Mintz J. Kern RS, et al. Among authors: marder sr. Schizophr Bull. 1999;25(2):223-32. doi: 10.1093/oxfordjournals.schbul.a033375. Schizophr Bull. 1999. PMID: 10416728 Clinical Trial.

5

Risperidone in treatment-refractory schizophrenia.

Wirshing DA, Marshall BD Jr, Green MF, Mintz J, Marder SR, Wirshing WC. Wirshing DA, et al. Among authors: marder sr. Am J Psychiatry. 1999 Sep;156(9):1374-9. doi: 10.1176/ajp.156.9.1374. Am J Psychiatry. 1999. PMID: 10484947 Clinical Trial.

6

Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.

Marder SR, Aravagiri M, Wirshing WC, Wirshing DA, Lebell M, Mintz J. Marder SR, et al. Schizophr Res. 2002 Jan 1;53(1-2):25-30. doi: 10.1016/s0920-9964(00)00184-5. Schizophr Res. 2002. PMID: 11728835 Clinical Trial.

7

The Mount Sinai conference on the pharmacotherapy of schizophrenia.

Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, Lieberman J, Schooler NR. Marder SR, et al. Schizophr Bull. 2002;28(1):5-16. doi: 10.1093/oxfordjournals.schbul.a006926. Schizophr Bull. 2002. PMID: 12047022 Review.

8

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J. Green MF, et al. Among authors: marder sr. Biol Psychiatry. 2002 Jun 15;51(12):972-8. doi: 10.1016/s0006-3223(02)01370-7. Biol Psychiatry. 2002. PMID: 12062881 Clinical Trial.

9

Sexual side effects of novel antipsychotic medications.

Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC. Wirshing DA, et al. Among authors: marder sr. Schizophr Res. 2002 Jul 1;56(1-2):25-30. doi: 10.1016/s0920-9964(01)00271-7. Schizophr Res. 2002. PMID: 12084416

10

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.

Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T. Marder SR, et al. Schizophr Res. 2003 Jun 1;61(2-3):123-36. doi: 10.1016/s0920-9964(03)00050-1. Schizophr Res. 2003. PMID: 12729864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters